Cargando…

High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival

SIMPLE SUMMARY: A recent point of focus in breast cancer (BC) research has been the utilization of cell-free DNA and its concentration (cfDConc) and integrity (cfDI) as potential biomarkers. Though the association of cfDConc and BC survival is already recognized, studies on the prognostic value of c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lamminaho, Maria, Kujala, Jouni, Peltonen, Hanna, Tengström, Maria, Kosma, Veli-Matti, Mannermaa, Arto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467852/ https://www.ncbi.nlm.nih.gov/pubmed/34572906 http://dx.doi.org/10.3390/cancers13184679

Ejemplares similares

High mutation burden of circulating cell‐free DNA in early‐stage breast cancer patients is associated with a poor relapse‐free survival
por: Kujala, Jouni, et al.
Publicado: (2020)

Circulating Cell-Free DNA Reflects the Clonal Evolution of Breast Cancer Tumors
por: Kujala, Jouni, et al.
Publicado: (2022)

Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival
por: Pelkonen, Mikko, et al.
Publicado: (2015)

SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?
por: Tengström, Maria, et al.
Publicado: (2012)

Predicting breast cancer risk using interacting genetic and demographic factors and machine learning
por: Behravan, Hamid, et al.
Publicado: (2020)

The debatable presence of PIWI‐interacting RNAs in invasive breast cancer
por: Kärkkäinen, Emmi, et al.
Publicado: (2021)

Expression profiles of small non-coding RNAs in breast cancer tumors characterize clinicopathological features and show prognostic and predictive potential
por: Kärkkäinen, Emmi, et al.
Publicado: (2022)

γ-Secretase Components as Predictors of Breast Cancer Outcome
por: Peltonen, Hanna M., et al.
Publicado: (2013)

Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls
por: Behravan, Hamid, et al.
Publicado: (2018)

Type II Transmembrane Serine Protease Gene Variants Associate with Breast Cancer
por: Luostari, Kaisa, et al.
Publicado: (2014)

Histone demethylase GASC1 - a potential prognostic and predictive marker in invasive breast cancer
por: Berdel, Bozena, et al.
Publicado: (2012)

Overexpression of MicroRNA-200c Predicts Poor Outcome in Patients with PR-Negative Breast Cancer
por: Tuomarila, Marie, et al.
Publicado: (2014)

Transcription factors zeb1, twist and snai1 in breast carcinoma
por: Soini, Ylermi, et al.
Publicado: (2011)

Nuclei instance segmentation from histopathology images using Bayesian dropout based deep learning
por: Gudhe, Naga Raju, et al.
Publicado: (2023)

FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome
por: Kiiski, Johanna I., et al.
Publicado: (2016)

Area-based breast percentage density estimation in mammograms using weight-adaptive multitask learning
por: Gudhe, Naga Raju, et al.
Publicado: (2022)

Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression
por: Jouppila-Mättö, Anna, et al.
Publicado: (2011)

Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression
por: Tuhkanen, Hanna, et al.
Publicado: (2009)

FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population
por: Kiiski, Johanna I., et al.
Publicado: (2017)

Multi-level dilated residual network for biomedical image segmentation
por: Gudhe, Naga Raju, et al.
Publicado: (2021)

Peritumor to tumor apparent diffusion coefficient ratio is associated with biologically more aggressive breast cancer features and correlates with the prognostication tools
por: Okuma, Hidemi, et al.
Publicado: (2020)

High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer
por: Sopo, Minna, et al.
Publicado: (2020)

Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer
por: Sallinen, Hanna, et al.
Publicado: (2014)

A FinnGen pilot clinical recall study for Alzheimer’s disease
por: Julkunen, Valtteri, et al.
Publicado: (2023)

High baseline Tie1 level predicts poor survival in metastatic breast cancer
por: Tiainen, Leena, et al.
Publicado: (2019)

XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study
por: Metsola, Katja, et al.
Publicado: (2005)

High regional mortality due to malignant melanoma in Eastern Finland may be explained by the increase in aggressive melanoma types
por: Suhonen, Ville, et al.
Publicado: (2021)

Prognostic factors in gastric carcinoma - reply
por: Setälä, Leena, et al.
Publicado: (1997)

Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer
por: Masarwah, Amro, et al.
Publicado: (2016)

Keratinocyte Growth Factor Induces Gene Expression Signature Associated with Suppression of Malignant Phenotype of Cutaneous Squamous Carcinoma Cells
por: Toriseva, Mervi, et al.
Publicado: (2012)

ERBB4 Promoter Polymorphism Is Associated with Poor Distant Disease-Free Survival in High-Risk Early Breast Cancer
por: Kurppa, Kari J., et al.
Publicado: (2014)

Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer
por: Sopo, Minna, et al.
Publicado: (2019)

Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility
por: Mantere, Tuomo, et al.
Publicado: (2017)

LGR5 overexpression confers poor relapse-free survival in breast cancer patients
por: Hou, Ming-Feng, et al.
Publicado: (2018)

Signaling pathways in human osteoclasts differentiation: ERK1/2 as a key player
por: Pennanen, Paula, et al.
Publicado: (2021)

Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
por: Fredholm, Hanna, et al.
Publicado: (2009)

AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice
por: Kujala, Anni, et al.
Publicado: (2022)

Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival
por: Henderson, Henry J., et al.
Publicado: (2017)

Videoconferencing Applications for Training Professionals on Nonverbal Communication in Online Clinical Consultations
por: Kyyhkynen, Rasmus, et al.
Publicado: (2023)

Integrated Multi-Omics Profiling of Young Breast Cancer Patients Reveals a Correlation between Galactose Metabolism Pathway and Poor Disease-Free Survival
por: Han, Xiangchen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8jp6q4965jam5cg9cj946bnh6d